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Abstract 
There is evidence that some health practitioners may be reluctant to disclose a diagnosis of 
Alzheimer's disease (AD) to patients (Clafferty, Brown, & McCabe, 1998; Drickamer & 
Lachs, 1992; Fortinsky, Leighton, & Wasson, 1995; Kirby & Maguire, 1998; Maguire et al., 
1996; Rice & Warner, 1994; Rice, Warner, Tye & Bayer, 1997).  However, this reluctance 
towards disclosure may not be in accordance with patient expectation (Erde, Evan, Nadal, & 
Scholl, 1988; Holroyd, Snustad, & Chalifoux, 1996; Kirby & Maguire, 1998; Maguire et al., 
1996; Vassilas & Donaldson, 1998).  This study examined the attitudes of 100 undergraduate 
psychology students towards disclosure practices in relation to AD, before and after exposure 
to AD education.  After AD education, 93% of participants indicated a desire to be informed 
of a diagnosis of AD, and 95% of participants were in favour of telling a close relative a 
diagnosis of AD.  Results are discussed in terms of the relationship between age and attitudes 
towards AD diagnosis.  It is concluded that the high rate of support for disclosure of AD 
diagnoses to patients among younger adults may reflect a change in the information 
preferences of patients brought about by a shift away from a patriarchal medical model, 
toward a more autonomous model of health. 
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Estimates of the prevalence of Alzheimer's disease (AD) in developed countries suggest 
that at least 3.7 million people may be affected (Alzheimer's Disease International, 1999).  In 
Australia, AD affects between 55,000 and 144,000 individuals, however the number of cases 
of AD is expected to double by the year 2011 (Woodward, 1999).  As the world's population 
ages and the incidence of AD increases, the treatment and management of those with AD will 
become an increasing public health concern (Brookmeyer, Gray, & Kawas, 1998).   
An important aspect of the effective care of people with AD is the manner in which the 
diagnosis of the disease is managed.  A particularly important part of this process, is how this 
information is conveyed to patients and their families.  Whilst some practice guidelines for the 
management of people with AD include sections on disclosure (e.g., American Psychiatric 
Association, 1997; American Psychological Association, 1998), the information provided may 
be too general and non-specific, if the issue is dealt with at all.  The need for guidance on this 
matter is apparent from previous research on the issue of disclosing diagnoses of AD, which 
suggests significant variation in practice, and also current debate in the literature on what 
constitutes best practice in this area (e.g., Rice et al., 1997).  For example, some practitioners 
advocate telling the patient his or her diagnosis, whereas other practitioners are reluctant to 
disclose this information to patients (Drickamer & Lachs, 1992; Kirby & Maguire, 1998; 
Maguire et al., 1996; Rice & Warner, 1994; Rice et al., 1997; Vassilas & Donaldson, 1998).   
To account for the reluctance of some practitioners to disclose AD diagnoses, some 
researchers have drawn parallels between attitudes towards disclosure of AD and cancer 
diagnoses (Buckman, 1996; Drickamer & Lachs, 1992; Green & Gantt, 1987; Noritoshi, 1998; 
Thomsen, Wulff, Martin, & Singer, 1993).  For example, an investigation by Oken of cancer 
surgeons in the United States in 1961, found that 90% of those questioned did not routinely 
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tell patients their diagnosis (as cited in Buckman, 1996).  Over time however, attitudes 
towards cancer diagnosis have changed considerably.  A replication of Oken's study in 1977 
found a complete reversal of attitude, with 97% of those surveyed indicating a willingness to 
disclose a diagnosis of cancer to their patients (Holroyd et al., 1996).   
It has been argued that many health professionals currently treating AD patients have 
the same reservations about disclosing an AD diagnosis to patients as those treating cancer 
patients in the 1960s (Drickamer & Lachs, 1992; Kirby & Maguire, 1998; Maguire et al., 
1996; Rice & Warner, 1994; Rice et al., 1997; Vassilas & Donaldson, 1998).  For example, a 
survey conducted by Vassilas and Donaldson (1998) showed that 95% of general practitioners 
would tell patients, always or often, a diagnosis of terminal cancer, but only 39% of this group 
would always or often tell patients a diagnosis of dementia.   
Some of the reasons given for the reluctance to tell AD patients their diagnosis are the 
same as those that have been advanced for not telling a patient they have cancer (Drickamer & 
Lachs, 1992).  For some practitioners there is the fear that delivering bad news may result in 
long-term harm to the patient's emotional well being.  For others, there is the concern about 
the certainty of the diagnosis of AD, and the belief that since there is no cure for the disease, a 
definitive diagnosis of AD is unimportant.  Other practitioners cite opposition by relatives to 
informing the patient of a diagnosis of AD as influential in their disclosure practice 
(Drickamer & Lachs, 1992; Kirby & Maguire, 1998; Miller et al., 1992).  
The shift in the disclosure practices of professionals treating cancer patients may be 
partially explained by improved cancer treatments and changes to legal liability laws (Holroyd 
et al., 1996).  Drickamer and Lachs (1992) have also argued that the empirical demonstration 
that patients do want to know their diagnosis has been influential in the change of attitude 
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towards truth disclosure with cancer.  However, it has been suggested that greater societal 
support for individual autonomy and a lesser acceptance of paternalistic medical practices 
may have exerted an even greater influence on changes to disclosure practices (Holroyd et al., 
1996). 
Most of the studies that have looked at the issue of disclosure of AD diagnoses have 
done so from the perspective of the health professional (Clafferty et al., 1998; Fortinsky et al., 
1995; Gilliard & Gwilliam, 1996; Holroyd et al., 1996; Rice & Warner, 1994; Rice et al., 
1997; Vassilas & Donaldson, 1998).  The few studies that have examined this issue from the 
viewpoint of the potential patient have suggested that attitudes held by some health 
professionals to the disclosure of a diagnosis of AD may differ significantly from the general 
public. 
For example, Erde and colleagues (1988) surveyed 224 individuals on the question of 
whether or not they would want to be told a diagnosis of AD.  Over 90% of respondents 
answered in the affirmative.  In another study with older adults (M = 79.7, SD = 6.9), results 
showed that 79.5% of participants would want to know a diagnosis of AD (Holroyd et al., 
1996).  Finally, a study of people with a first-degree relative with AD showed that 71% would 
want to be told their diagnosis (Maguire et al., 1996).  Reasons given for wanting to know a 
diagnosis of AD have included the right to know, to make provisions for the future, to explore 
treatment options, to commit suicide, to get a second opinion, to settle family matters, to 
travel or go on a vacation, to understand what is happening, to prepare spiritually, and to find 
out as much as possible about the disease (Erde et al., 1988; Holroyd et al., 1996; Maguire et 
al., 1996).   
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An interesting contradictory result was found when researchers asked individuals 
whether they believed that a close relative with AD should be told his or her diagnosis.  
Holroyd and colleagues (1996) found that only 65.7% of respondents would want their spouse 
told a diagnosis of AD; a lower percentage than the 79.5% who expressed a desire to be told 
their own diagnosis of the disease.  In excess of 80% of the 100 participants in the study by 
Maguire and colleagues (1996) did not believe it was appropriate for a family member be told 
a diagnosis of AD.  This is in marked contrast to the 71% who indicated that they themselves 
would want to be told a diagnosis of AD.  In a letter to the editor, Rice and colleagues (1997) 
reported the results of an unpublished survey of 40 carers of people with AD.  Ninety percent 
of these participants said that they did not believe the patient should be told a diagnosis of 
AD.  Included in the reasons provided for not wanting to disclose a diagnosis of AD to a close 
family member was that the diagnosis would depress or agitate the relative, the relative would 
not understand the diagnosis, that there is no benefit in knowing, the relative would not want 
to be told, and the fear that the relative may commit suicide (Holroyd et al., 1996; Kirby & 
Maguire, 1998; Maguire et al., 1996; Vassilas & Donaldson, 1998).   
In contrast to the findings of the majority of studies on this issue however, Barnes 
(1997) found that the majority of first-degree relatives of patients with AD were in favour of 
telling the relative a diagnosis of AD.  It should be noted that Barnes' (1997) study was 
described in a letter to the editor, thus it is difficult to comment on potential differences in 
methodology that could account for this discrepancy.  Nonetheless, this inconsistency in 
results suggests there may be a need for further research to clarify how people feel about 
disclosing AD diagnoses to relatives, and whether there is a difference between people's 
attitudes when thinking about disclosure in relation to themselves or to others. 
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Previous studies have attempted to identify demographic markers of those with 
differing preferences for medical information (Benbassat, Pilpel, & Tidhar, 1998; Deber, 
1994; Petrisek, Laliberte, Allen, & Mohr, 1997; Walsh, Girgis, & Sanson-Fisher, 1998).  
These studies have suggested that at least two factors may influence individuals' information 
preferences.  These are: patient age and knowledge of the disease in question (Benbassat et 
al., 1998, Meredith et al., 1996; Petrisek et al., 1997, Welkenhuysen, Evers-Kieboom, & Van 
den Berghe, 1997).  For instance, age has been found to influence the patient-doctor 
relationship, such that older individuals (60 years of age and above) adopt a more passive role 
in the consultation process with their doctors than younger individuals (Benbassat et al., 
1998).  The paternalistic medical model, widespread in the 1950s, may have instilled in older 
individuals an expectation that the patient should be a passive receiver of medical treatment 
with the doctor taking control of the consultation process (Benbassat et al., 1998).  Younger 
individuals may be influenced by a more egalitarian medical model in which patients are 
encouraged to take greater responsibility for their health care (Petrisek et al., 1997).  Given 
that age may influence the degree to which an individual participates in the medical decision-
making process, it seems reasonable to expect that the desire to be told a diagnosis, or to give 
permission to tell a diagnosis, may differ with the age of the person making this decision.  
Research on the relationship between age and attitudes to the disclosure of an AD 
diagnosis has been limited and in some cases poorly designed.  For example, Erde and 
associates (1988) concluded from their study that no demographic marker could predict an 
individual's attitude to AD diagnosis disclosure.  However, the mean age and lower- and 
upper-limits of the age range of participants in their study were not reported.  Thus, it is 
difficult to comment on attitudes to diagnosis disclosure at specific age periods.  
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In addition, although Holroyd and associates (1996) have stated that they were unable 
to find a demographic marker, including age, which would be useful for distinguishing 
between those individuals in favour and those against diagnosis disclosure, their study only 
older individuals (M = 79.7, SD = 6.9).  This would seem to limit extensive comments on 
disclosure attitudes as a function of age.   
Nonetheless, the study by Erde and colleagues has arguably made the most 
comprehensive attempt to explore the relationship between age and attitudes towards 
diagnosis to date.  For example, Erde and colleagues (1988) endeavoured to gauge attitude 
changes to diagnosis disclosure as a function of age, using an age projection technique.  This 
technique involved asking participants to imagine how they would feel about the disclosure of 
a diagnosis of AD at ages ranging from 40 to 90 years old.  As has been noted however, an 
individual's cohort may influence his or her preference for medical information (Benbassat et 
al., 1998; Petrisek et al., 1997), thus age projection techniques may not be the most effective 
means of assessing age differences in attitudes to diagnosis disclosure. 
Another means of determining whether there is a relationship between age and 
attitudes towards disclosure of AD diagnoses, is to compare results across cross-sectional 
studies with "older" and "younger" samples.  For example, in the study conducted by Holroyd 
and colleagues (1996), which involved "older" subjects (participants mean age was 79.7), a 
lower percentage (79.5%) of the sample was in favour of diagnosis disclosure than the 
"younger" subjects tested by Erde and associates (1988; 80% of the sample were described as 
under the age of 65).  There are at least two limitations associated with making this type of 
comparison that need to be acknowledged however, before accepting this comparison as 
evidence of a trend in the data.  First, as noted above, the age of the sample included in the 
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study by Erde and colleagues is difficult to estimate, thus the extent to which this comparison 
provides a reasonable test of the proposition that age is related to disclosure preferences is 
difficult to determine.  Second, direct comparison of percentages across studies can at best 
provide a weak test of this proposition, given that differences may be due to a range of 
variables that were not equally controlled.  Nonetheless, when considered in light of relevant 
theoretical models, this pattern of results may suggest a trend in the data.  That is, if older 
people are more reluctant to want to be told their diagnosis than younger people, this would be 
consistent with the age/autonomy model of health-seeking behaviour, which posits that older 
individuals are less likely than younger people to explicitly seek information about their 
medical condition.   
Lack of AD knowledge has also been implicated in a reduction of the information 
seeking behaviour of some older individuals (Boise, Morgan, Kaye, & Canicolli, 1999).  For 
instance, when quizzed on the possible reasons for the delay in obtaining a diagnosis of AD 
for a family member, 72% of caregivers surveyed by Boise and associates (1999) indicated 
that it was because they did not know very much about AD.  Since lack of AD knowledge has 
been shown to affect an individual's information seeking behaviour, attitudes towards 
diagnosis disclosure may also be affected by a lack of AD knowledge.   
This review of the literature on attitudes towards AD diagnosis for self and others 
illustrates a number of important points.  First, contrary to the opinions and practice of some 
health professionals, which suggests there may be a reluctance to disclose a diagnosis of AD 
to some patients, the general consensus in the literature appears to be that most people would 
want to be told a diagnosis of AD if they were to develop the disease (Barnes, 1997; Erde et 
al., 1988; Holroyd et al., 1996; Maguire et al., 1996; Rice & Warner, 1994).  Second, there 
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may be a discrepancy in people's attitudes towards diagnosis when they consider this issue in 
relation to themselves and to others, at least for older adults (Barnes, 1997; Holroyd et al., 
1996; Maguire et al., 1996; Rice & Warner, 1994).  Whether this pattern of results reflects the 
attitudes of younger people remains unknown however.  Third, although there are clearly 
people who, do not want to be told a diagnosis of AD (Girgis & Sanson-Fisher, 1998), 
however the reasons for this may vary and could include a lack of knowledge about the 
disease.  Fourth, although attempts have been made to discover a means of predicting those 
who favour the disclosure of an AD diagnosis and those who oppose it, based on the available 
literature, it appears that we can not tell in advance who will and who will not want to be told 
their diagnosis.  However, as noted previously, there may be a need to further investigate the 
potential role of age as a possible predictor given restrictions on this variable in previous 
studies.  Fifth, and perhaps most importantly, this review of the literature shows there are 
serious limits to our knowledge in relation to attitudes towards AD diagnoses.  Although there 
may sound methodological reasons for studies to focus on older adults, given that the prospect 
of developing the disease may be perceived as a more serious risk for this age group 
(Welkenhuysen et al., 1997), thus there may be more concordance between older people's 
attitudes and behaviour in relation to AD, an understanding of younger adults' attitudes 
towards diagnosis is also clearly important.   
The aims of this study were two-fold.  The first aim of this study was to explore the 
attitudes of younger adults to the disclosure of a diagnosis of AD.  Importantly, it was 
anticipated that mean age for the sample used in this study would be lower than that used in 
previous studies.  Since younger individuals may be more heavily influenced by the current 
autonomy based model of health care than older individuals (Petrisek et al., 1997), it was 
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predicted that a large majority of individuals in this study would approve of the disclosure of a 
diagnosis of AD for themselves and for others.  Although it is difficult to make comparisons 
across studies as noted previously, it was anticipated that the size of the "majority" supporting 
disclosure in this study would be greater than that found in previous studies with older adults.   
The second aim of this study was to examine the relationship between knowledge of 
AD and attitudes to diagnosis disclosure.  Given that a reduction in information seeking 
behaviour has been noted previously in those with a lack of AD knowledge (Boise et al., 
1999), it was expected that individuals with a greater knowledge of AD would be more likely 
to support being told their diagnosis of AD than individuals with less knowledge of AD.  
Method 
Participants 
 
Seventy-five first year undergraduate psychology students from Queensland 
University of Technology (QUT) and twenty-five first year undergraduate psychology 
students from James Cook University (JCU) participated in this study (females = 79; males = 
21).  Age of participants ranged from 17 to 56 (M = 26.83, SD = 10.17).   Participants in this 
study received course credit points in return for participation. No significant group differences 
in age were apparent, F(3,96) = 1.47, p = .227, nor were there significant gender differences 
between groups, χ2 (3) = 4.52, p = .210. 
Materials 
 
The Reasons for Wanting to Know Questionnaire (RWK) was developed for this study 
to assess attitudes towards diagnosis disclosure and was based on scales used in previous 
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research (Erde et al., 1988; Holroyd et al., 1996; Maguire et al., 1996).  The RWK was 
circulated to attendees at a meeting of the Australian Psychological Society’s College of 
Clinical Neuropsychologists Queensland branch, prior to use in this study to ensure 
appropriate content and clarity.  No changes to the scale content or format were made as a 
result of this process.   
The RWK was intended to assess whether an individual would want to be told a 
diagnosis of AD should they develop the disease.  It was also intended to assess whether an 
individual would approve of a close relative being told a diagnosis of AD, if they were to 
develop the disease.  A number of reasons for and against diagnosis disclosure were listed on 
the RWK and participants were asked to rate their importance on a five-point Likert scale, 
ranging from very important to very unimportant.  Participants were asked to circle the 
number that best represents the importance to them of the reason given.  Figure 1 shows a 
sample RWK item.  Copies of the RWK are available from the first author on request. 
 
Insert Figure 1 about here 
 
The Alzheimer's Disease Knowledge Test (ADK; Dieckmann, Zarit, Zarit, & Gatz, 
1988) was also administered to participants in this study.  The rationale for selecting the 
ADK, and the modifications made to this instrument for the purposes of this study have been 
described fully elsewhere (Sullivan & O'Conor, in press).  Briefly the ADK is an established 
measure of knowledge of AD, that was designed to be used as an evaluative tool and 
continues to be used for this purpose (e.g., Karlin & Dalley, 1998).  In it's original format, the 
ADK is a twenty-item instrument that includes items presented as multiple choice questions, 
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each with a "don't know" option to discourage guessing of answers (Dieckmann et al., 1988).  
For this study, two items were dropped from the scale, and the response options for three 
items were changed in line with the scale authors recommendations that items be updated to 
reflect current knowledge. 
Procedure 
 
The full procedure for this study has been described previously (Sullivan & O'Conor, 
in press) but will be described here briefly.  Participants were tested over two sessions held 
one week apart.  Students from QUT were randomly assigned to one of three groups before 
the start of session one.  Students from JCU were assigned to a control group.  In session one, 
participants were told about the study, invited to ask questions and requested to sign a consent 
form.  Each participant filled out a copy of the ADK and the RWK.  
At session two, QUT students were exposed to education intervention depending upon 
group allocation.  That is, some students were provided with written information about AD, 
others saw a video about AD, and the remainder were exposed to both types of information.  
The control group (JCU students) did not undergo any education.  The written information 
was presented as an information sheet entitled, "Alzheimer's disease - What is it?" 
(Alzheimer's Association of Queensland, 1995) and participants in the video condition viewed 
a segment from a programme called "You must remember this: Inside Alzheimer's disease" 
(Film Australia, 1990).  Education materials were obtained from the Alzheimer’s Association 
of Australia (Queensland branch) because materials produced by this group have been shown 
to be effective in educating the public about AD (Boise et al., 1999).  Administration of the 
ADK and the RWK was repeated at session two for all participants. 
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Results 
Results for the analyses of the RWK are presented descriptively following a precedent 
set by other researchers (Erde et al., 1988; Holroyd et al., 1996; Maguire et al., 1996).  
Preference for being told a diagnosis of AD, or telling a close relative a diagnosis of AD, did 
not change significantly after education, χ2 (4) = 23.23, p = .000, therefore results following 
education are reported only.  However, it should be noted that detailed results from the ADK, 
addressing the most effective means of improving knowledge of AD, have been reported 
elsewhere (Sullivan & O'Conor, in press). 
Ninety-three percent of participants responded in favour of being told a diagnosis of 
AD, and 95% of participants indicated in favour of telling a close relative a diagnosis of AD.  
Table 1 illustrates the results of the question of whether or not an individual supports the 
disclosure of a diagnosis of AD.  
 
Insert Table 1 about here 
 
The Likert scale data obtained from RWK was collapsed into two categories: (a) very 
or moderately important and (b) very or moderately unimportant to simplify data analysis.  
Table 2 presents the reasons that were considered important both for wanting to know a 
diagnosis of AD and for not wanting to know a diagnosis of AD.  For example, Table 2 shows 
that 96% of those participants who said that they would want to know a diagnosis of AD 
indicated that an important reason for this was the belief they had a "right to know".  For those 
participants against diagnosis disclosure (n = 3), the fact that they would not want to be 
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informed of any illness was nominated by all respondents as an important reason for their 
attitude against disclosure of an AD diagnosis. 
 
Insert Table 2 about here 
 
Table 3 shows the reasons that were considered important for telling or not telling a close 
relative a diagnosis of AD.  For example, 94% of those participants in favour of disclosing a 
diagnosis of AD to a close relative, indicated that the patient's "right to know" was an 
important motive for disclosure.  The fear of upsetting the relative by disclosing a diagnosis of 
AD was important for those participants who said they did not support telling a close relative 
a diagnosis of AD.   
 
Insert Table 3 about here 
 
Of those participants who indicated that they would want to know a diagnosis of AD 
(see Table 2), 96% indicated that an important reason for this was their right to know.  To 
plan ahead, explore treatment options, to get a second opinion, and to settle family matters 
were also considered important to the majority of respondents (i.e., more than 87% of this 
group).  Nine percent of participants indicated that being able to plan their suicide was also an 
important consideration.  Of those participants who were in favour of telling a diagnosis of 
AD to a close relative (See Table 3), the relative's right to know was considered important by 
94% of this group.  Most respondents (92% of this group) also indicated that they believed the 
relative would cope better if he or she were told a diagnosis of AD.   
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Discussion 
The aims of this study were two-fold.  First, to explore the attitudes of younger adults 
to the disclosure of a diagnosis of AD; and second to examine the relationship between AD 
knowledge and attitudes to diagnosis disclosure in younger adults. 
To achieve these aims, two hypotheses were proposed.  First, the hypothesis, that a 
large majority of individuals in this study would approve of the disclosure of a diagnosis of 
AD for themselves and for others, was supported.  Results pertaining to attitudes towards 
diagnosis for self are discussed first, followed by results pertaining to attitudes towards 
disclosure for others. 
In this study, 93% of participants responded in favour of being told a diagnosis of AD.  
The high percentage of participants in this study who said that they would want to know a 
diagnosis of AD is in accordance with the study by Erde and colleagues (1988) whose 
participants were mostly younger than 65 years old.  In addition, the percentage of the 
participants in this study indicating a desire to be told a diagnosis of AD (93%), is higher than 
that found in studies with older adults (i.e., 79.5%; Holroyd et al., 1996).  This finding appears 
to provide further support for the proposition that there may be age differences in people's 
attitudes towards disclosure of AD diagnoses, given that studies with older adults suggest a 
lower percentage of participants are in favour of disclosure (Holroyd et al., 1996).  However, 
these results need to be interpreted cautiously, since, as noted previously, comparisons of 
percentages derived from cross-sectional research can be problematic if sample characteristics 
are not equivalent.  Therefore, to fully investigate the issue of the relationship between age 
and attitude towards the disclosure of a diagnosis of AD, a study that includes participants 
from a wide range of age groups may be warranted. 
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As noted previously, differences between younger individuals and older adults have 
been noted in relation to the patient-doctor relationship generally (Benbassat et al., 1998).  
This difference has been attributed to a changing medical model with younger individuals 
expecting to take a more active role in this relationship than older individuals (Benbassat et 
al., 1998).  This influence may also extend to an individual’s information seeking practices; 
with those influenced by the autonomous medical model expecting a more egalitarian 
exchange of information with their doctors.  However, further exploration of the relationship 
between age and attitude towards diagnosis disclosure is needed, to determine whether 
apparent differences between the attitudes of younger and older adults can be attributed to an 
autonomous medical model, such as that proposed by Benbassat and associates (1998).  For 
example, this could be done by including a questionnaire that assesses attitudes toward the 
doctor-patient relationship specifically.  
Previous research has found that people tend to be more in favour of being told a 
diagnosis of AD themselves than of telling a close relative his or her diagnosis (Holroyd et al., 
1996; Maguire et al, 1996).  In accounting for this inconsistent finding, Maguire and 
colleagues (1996) have suggested that some individuals who endorse autonomous decision-
making with regards to their own health, may take a more paternalistic view when considering 
the information needs of those close to them.  That is, they may fail to deliver (or have 
delivered) bad news in an effort to protect loved ones.  Contrary to this pattern of results, 
participants in this study were equally supportive of being told (93%) and telling a close 
relative a diagnosis of AD (95%).  Again, this result may be a reflection of the profound 
influence of the autonomous medical model on younger people.  
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The second hypothesis for this study, that individuals with a greater knowledge of AD 
would be more likely support being told their diagnosis of AD than individuals with less 
knowledge of AD, could not be tested in this study.  Examination of the relationship between 
knowledge of AD and attitudes towards the disclosure of a diagnosis of AD was made 
difficult due to the large numbers of individuals in favour of diagnosis disclosure.  As has 
been noted, the heavy bias towards wanting to know a diagnosis of AD may illustrate the 
extent to which young people are influenced by the autonomous medical model.   
However, this finding raises two important issues.  First, the results of this study 
suggest that even when provided with information about AD, participants support for 
disclosure remained high.  That is, support for disclosure did not decline after participants 
were provided with information about AD, even though their knowledge of the disease 
increased following education (see Sullivan & O'Conor, in press).  This result may contradict 
some of reasons against disclosing diagnoses to patients that have been reported in the 
literature.  For example, Markle (1993) has suggested that "…given the distressing facts [of 
diagnosis] many patients, while still able, would simply shoot themselves" (p. 736).  While 
this perspective is probably not be representative of the views held by most doctors, the 
results of this study suggest that even when provided with "the distressing facts", such as the 
incurable nature of the disease, the likely level of dependency, and the serious and debilitating 
cognitive symptoms, younger adults continue to want to be told their diagnosis. 
Secondly, it is important to note that this is the first time the relationship between 
education and attitudes towards disclosure of a diagnosis of AD has been investigated in 
young people, and the relationship between these variables has yet to be explored with older 
individuals.  Considering that there may be more variation in older people's attitudes towards 
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disclosure, it may be possible to measure the effect of knowledge on attitudes with an older 
sample.  That is, examination of the relationship between AD knowledge and disclosure 
attitudes of older individuals may provide some insight into the possible link between these 
variables.  In addition, future studies could also look at using a non-university based sample of 
younger adults to further explore the potential relationship between education and attitudes 
towards diagnosis, given that the general public may demonstrate more variation in attitudes 
towards disclosure than the sample used in this study.  Using both older and non-university 
based samples who may have less education than subjects used in this study may also permit 
further investigation of the relationship between education and disclosure preference. 
The reasons given by individuals both in favour and against disclosure of AD 
diagnoses are interesting and may have important implications for the management of people 
with AD and their families.  For example, individuals who supported the disclosure of a 
diagnosis of AD indicated that being able to get a second opinion about the diagnosis, to plan 
ahead, to explore treatment options, and to settle family matters, were important reasons for 
this.  Having a right to know was considered important both by those who favoured being told 
a diagnosis of AD and those who supported telling a close relative a diagnosis of AD.  This 
support for patient’s rights lends further credence to the autonomy theory of individuals’ 
information preferences in this sample.   
A small number of individuals indicated that it was important for them to be told a 
diagnosis of AD in order to plan for their suicide.  Recently, there have been two documented 
cases of suicide in patients with probable AD, however the risk of suicide amongst those with 
AD is generally considered low (Rohde, Peskind, & Raskind, 1995).  Nonetheless, the results 
of the present study suggest that suicide is a real consideration for a small percentage of 
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individuals and as such, suicide risk management must be considered as part of the process of 
managing disclosure of AD diagnoses.  
Apart from not wanting to distress clients (Markle, 1993), one of the other reasons 
cited by medicos for not disclosing diagnoses is inability to understand diagnsoses.  For 
example, it has been argued that in advanced cases, the client would not be able to understand 
the information (Rice & Warner, 1994), although others point out there may be other benefits 
for the patient in disclosing diagnostic information (Brodaty, Griffin, & Hadzi-Pavolvic, 
1990).  In response to concerns about the patients' ability to comprehend a diagnosis, some 
doctors have indicated they may be more likely to tell relatives than the patient themselves, 
especially in advanced cases.  Further, the practice of telling relatives and not patients may 
also occur at specialist diagnostic services that take a team approach to assessment and 
diagnosis of people with AD (e.g., Gilliard & Gwilliam, 1995).  Nonetheless, it is important to 
note that other health professionals have raised concerns about the legal and ethical 
implications of such practices (Barnes, 1997; Drickamer & Lachs, 1993; Meyers, 1997; Rice 
et al., 1997).  For example, some of the concerns that have been documented in the literature 
relate to whether the disclosure of information about a patient to their relatives, and not to the 
patient themselves, can in fact be justified.  Obviously, this is a difficult issue that medicos 
and other health professionals are currently attempting to grapple with. 
The dissemination of the results from this study may assist health professionals to 
better understand individuals' information preferences with regard to AD diagnoses.  If these 
results can be replicated, this may help begin a process of building up sufficient evidence to 
warrant the development of best practice guidelines on this issue.  These could be 
incorporated in future best practice guidelines, as a means of supporting practitioners involved 
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in managing the disclosure process.  In the meantime, this study has provided the first 
empirical demonstration that an overwhelming number of young people would want to know 
their diagnosis, should they developed AD, and indeed they consider it a right, even when 
after they have been provided with facts about the disease.  Importantly, this demonstration 
may be sufficient to begin changing disclosure practices of AD health professionals, in the 
same way that the knowledge of attitudes to cancer diagnosis may have contributed to a 
revision of disclosure practices for cancer diagnoses.  
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Table 1 
 
Percentage of Participants in Favour and Against the Disclosure of a Diagnosis of Alzheimer's 
Disease (AD) a. 
  
 Would want to be told 
a diagnosis of AD 
Would want to tell a close 
relative a diagnosis of AD 
Group Yes No Yes No 
 
Written 
 
19 
 
1 
 
19 
 
2 
Video 20 2 20 1 
Written/Video 20 1 20 0 
Control 
 
Total 
21 
 
80 
2 
 
6 
21 
 
80 
1 
 
4 
 a Missing data is excluded from calculation therefore percentages do not total 100 
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Table 2 
 
Reasons for and Against Being told a Diagnosis of Alzheimer's Disease (AD) 
 
Reasons to be told a 
Diagnosis of AD 
% Na Reasons not to be told a  
Diagnosis of AD 
% Na 
 
Plan ahead for future 
 
95 
 
72 
 
Don't want to know of any illness 
 
100 
 
3 
Have a right to know 96 74 No benefit in knowing 100 3 
Explore treatment options 94 72 Diagnosis would depress or agitate 75 3 
Get a second opinion 88 63 Fear of committing suicide 50 2 
Settle family matters 91 68 Stigma of the diagnosis   0 0 
Go on holiday/travel 73 44    
Plan my suicide 
 
  9   6    
 a Missing data and participants who were undecided are excluded  from calculation  
   therefore N does not total 100  
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Table3 
 
Reasons for and Against Telling a Diagnosis of AD to a Close Relative  
 
Reasons to tell a Close Relative a  
Diagnosis of AD 
% Na Reasons not to tell a Close 
Relative a Diagnosis of AD 
% N
a 
      
Has a right to know 94 79 Don't want to upset him/her 100 2 
Could try to keep mind working 81 56 Relative dreads the disease 100 1 
Would be aware he/she was ill 93 78 Stigma of the diagnosis 100 2 
Would cope better if he/she knew 92 54 Relative may commit suicide 100 1 
Understand why he/she forgets things 87 66 Wouldn't understand diagnosis 100 1 
To sort out legal affairs 84 63 No benefit in knowing 0.0 0 
To give consent to drug trials 69 50 They wouldn't want to know 100 1 
No use hiding it 72 43    
Could work it out for him/herself 55 33    
 a Missing data and participants who were undecided are excluded  from calculation   
  therefore N does not total 100  
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Figure Caption 
 
Figure 1.  Example of an item on the Reasons for Wanting to Know Questionnaire (RWK) 
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Reason                                                                                    Rating 
a.    I have a right to know                                      1-----2-----3-----4-----5 
b.   To plan ahead for my future                              1-----2-----3-----4-----5 
c.    To get a second opinion                                   1-----2-----3-----4-----5 
d.    To settle family matters                                    1-----2-----3-----4-----5 
 
1 = Very important, 2 = Moderately important, 3 = Undecided,  
4 = Moderately unimportant, 5 = Very unimportant               
     
 
 
 
